Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China

Vaccine

Volumn 31, Issue 35, 2013, Pages 3536-3542

  Connie Leung, Y H ^a   Luk, Geraldine ^b   Sia, Sin Fun ^a   Wu, Yu On ^a   Ho, Chuk Kwan ^a   Chow, Kai Chi ^a   Tang, Shing Chun ^a   Guan, Yi ^a   Malik Peiris, J S ^a,c  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b DEPARTMENT OF HEALTH   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antigenic drift; Avian influenza H5N1; Protection; Vaccine

Indexed keywords

AVIAN INFLUENZA VACCINE; HARBIN RE 5; HEMAGGLUTININ; NOBILIS INFLUENZA H 5N 2; POULVAC H 5N 3 VACCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; CHICKEN; CHINA; CONTROLLED STUDY; CROSS PROTECTION; DRUG EFFICACY; GERMFREE ANIMAL; HEMAGGLUTINATION INHIBITION; HONG KONG; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; NONHUMAN; POULTRY; PRIORITY JOURNAL; VIRUS EXCRETION; VIRUS IMMUNITY; VIRUS MUTATION; VIRUS SHEDDING; VIRUS STRAIN;

ANTIGENIC DRIFT; AVIAN INFLUENZA H5N1; PROTECTION; VACCINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENIC VARIATION; CHICKENS; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HONG KONG; IMMUNE EVASION; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POULTRY; POULTRY DISEASES; SEQUENCE ALIGNMENT; VACCINATION;

EID: 84880717761     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.05.076     Document Type: Article

References (28)

1. Sims L.D., Peiris M., One Health The Hong Kong experience with Avian Influenza. Curr Top Microbiol Immunol 2012, August.
2. Lau E.H., Leung Y.H., Zhang L.J., Cowling B.J., Mak S.P., Guan Y., et al. Effect of interventions on influenza A (H9N2) isolation in Hong Kong's live poultry markets, 1999-2005. Emerg Infect Dis 2007, 13(September (9)):1340-1347.
3. Leung Y.H., Zhang L.J., Chow C.K., Tsang C.L., Ng C.F., Wong C.K., et al. Poultry drinking water used for avian influenza surveillance. Emerg Infect Dis 2007, 13(September (9)):1380-1382.
4. Ellis T.M., Sims L.D., Wong H.K.H., Wong C.W., Dyrting K.C., Chow K.W., et al. Use of avian influenza vaccination in Hong Kong 2006, Karger, Paris, France.
5. Peyre M., Samaha H., Makonnen Y.J., Saad A., Abd-Elnabi A., Galal S., et al. Avian influenza vaccination in Egypt: limitations of the current strategy. J Mol Genet Med 2009, 3(2):198-204.
6. Sims L.D., Guan Y., Ellis T.M., Liu K.K., Dyrting K., Wong H., et al. An update on avian influenza in Hong Kong 2002. Avian Dis 2003, 47(September (s3)):1083-1086.
7. Ellis T., Leung Y.H.C., Chow Mary K.W., Bissett L.A., Wong W., Guan Y., et al. Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission. Avian Pathol 2004, 33:405-412.
8. Ellis T.M., Dyrting K.C., Wong C.W., Chadwick B., Chan C., Chiang M., et al. Analysis of H5N1 avian influenza infections from wild bird surveillance in Hong Kong from January 2006 to October 2007. Avian Pathol 2009, 38(2):107-119.
9. Smith G., Vijaykrishna D., Ellis T., Dyting K., Leung Y., Bahl J., et al. Characterization of Avian Influenza Viruses A (H5N1) from Wild Birds, Hong Kong, 2004-2008. Emerg Infect Dis 2009, 15(3):402-407.
10. Ellis T.M., Sims L.D., Wong H.K.H., Bissett L.A., Dyrting K.C., Chow K.W., et al. Evaluation of vaccination to support control of H5N1 avian influenza in Hong Kong. Wageningen UR frontis series: avian influenza, prevention and control 2004, Kluwer Academic Publishers. G.K.R. Schrijver (Ed.).
11. OIE. Update on highly pathogenic avian influenza in animals (Type H5 and H7).
12. WHO. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines; 2009. Available from: http://www.who.int/csr/disease/avian_influenza/guidelines/200902_H5VaccineVirusUpdate.pdf.
13. OIE. Manual of diagnostic tests and vaccines for terrestrial animals 2009, Avian Influenza; 2009. Available from: http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/2.03.04_AI.pdf.
14. Karber G. 50% end-point calculation. Arch Exp Pathol Pharmak 1931, 162:480-483.
15. Plotkin J.B., Dushoff J., Levin S.A. Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci USA 2002, 99(April (9)):6263-6268.
16. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25(39-40):6852-6862.
17. Swayne D.E., Garcia M., Beck J.R., Kinney N., Suarez D.L. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 2000, 18(11-12):1088-1095.
18. Evaluation of vaccination to support control of H5N1 avian influenza in Hong Kong 2005, Springer, Wageningen. T.M. Ellis, L.D. Sims, H.K.H. Wong, L.A. Bissett, K.C. Dyrting, K.W. Chow (Eds.).
19. Kaverin N.V., Rudneva I.A., Govorkova E.A., Timofeeva T.A., Shilov A.A., Kochergin-Nikitsky K.S., et al. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 2007, 81(December (23)):12911-12917.
20. Rockman S., Camuglia S., Vandenberg K., Ong C., Baker M.A., Nation R.L., et al. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies. Mol Immunol 2012, 53(November (4)):435-442.
21. Cattoli G., Milani A., Temperton N., Zecchin B., Buratin A., Molesti E., et al. Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus. J Virol 2011, 85(September (17)):8718-8724.
22. Wantanabe Y., Ibrahim M.S., Ellakany H.F., Kawashita N., Daidoji T., Takagi T., et al. Antigenic analysis of highly pathogenic avian influenza virus H5n1 sublineages co-circulating in Egypt. J Gen Virol 2012, 93(October (10)):2215-2226.
23. Li Y., Shi J., Zhong G., Deng G., Tian G., Ge J., et al. Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009. J Virol 2010, 84(September (17)):8389-8397.
24. Smith G.J.D., Fan X.H., Wang J., Li K.S., Qin K., Zhang J.X., et al. Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci USA 2006, 103(November (45)):16936-16941.
25. Escorcia M., Vazquez L., Mendez S., Rodriguez-Ropon A., Lucio E., Nava G. Avian influenza: genetic evolution under vaccination pressure. Virol J 2008, 5(1):15.
26. Hafez M.H., Arafa A., Abdelwhab E.M., Selim A., Khoulosy S.G., Hassan M.K., et al. Avian influenza H5N1 virus infections in vaccinated commercial and backyard poultry in Egypt. Poult Sci 2010, 89(August (8)):1609-1613.
27. Grund C., Abdelwhab E.S., Arafa A.S., Ziller M., Hassan M.K., Aly M.M., et al. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Vaccine 2011, January.
28. Gillim-Ross L., Santos C., Chen Z., Aspelund A., Yang C-F., Ye D., et al. Avian influenza H6 viruses productively infect and cause illness in mice and ferrets. J Virol 2008, 82(November (21)):10854-10863.